Maurizio Cecconi is a British-Italian anesthesiologist, intensivist, and academic. Cecconi's research focuses on improving the outcomes of high risk surgical patients, especially with better risk identification and perioperative haemodynamic optimisation, and improving the outcome of critically ill patients, especially suffering from cardiovascular shock, acute respiratory failure and sepsis. He has been Clinical Director of Adult Critical Care at St George's and the Clinical Lead for critical care at Epsom and St Helier's hospital from 2015 to 2016. He was President of the European Society of Intensive Care Medicine (ESICM) from 2020 to 2022 throughout the COVID-19 Pandemic. Cecconi has been the Head of the Department and Full Professor of Anaesthesia and Intensive Care at Humanitas Research Hospital and Humanitas University since 2018.
Biography
Cecconi attended the Scientific High School G. Marinelli in Udine. Cecconi graduated from the University of Udine in 2002. He won a grant from the Italian Society of Anaesthesia, Analgesia and Intensive Care (SIAARTI) and became a visiting fellow at St George's Hospital. At St George, Cecconi studied perioperative haemodynamic optimisation of the high risk surgical patient. He studied the evaluation of novel techniques for measuring cardiac output in critically ill patients, and in 2007 he got his Doctor of Medicine from the University of London. Cecconi got a scholarchip to study for a semester at the Autonomous University of Madrid in 2001. He completed his research studies with a research programme GCSRT at Harvard Medical School in 2015.
In 2008, Cecconi worked as a consultant for the NHS and became one of the youngest NHS consultants.
In 2011, Cecconi became the Research Lead for the Adult Critical Care Directorate at St. George's University Hospitals in London, and then became its Clinical Director in 2016.
In 2016, Cecconi became the Clinical Director of Adult Critical Care at St George's Hospital in London and the Clinical Lead for critical care at Epsom and St Helier's hospital.
In February 2018, and after 13 years in the UK, Cecconi returned to Italy to work for Humanitas.
In a 2018 interview with Il Giorno, Cecconi said he returned to Italy to work at Humanitas due to its alignment with his vision of medicine combining clinical work and research. He is known for advocating a vision of anesthesia and intensive care that emphasizes the importance of research and patient outcomes.
Cecconi said that his focus is on optimizing critically ill patients and high-risk surgical patients with tailored protocols. In another 2018 interview to a local publication, he said: This means maintaining homeostasis in terms of pressure, oxygen transport, and cardiac output during and after the first few hours of surgery," he explained. "This practice has been shown to reduce the risk and postoperative complications and hospital stays. It improves the quality of hospitalizations and makes hospitals more efficient. Saint George's Hospital has always been a pioneer in this field, and I was able to do my research doctorate with them.
COVID-19
The outbreak began on February 20 when a man in his 30s was admitted to Codogno Hospital, leading to 36 COVID-19 cases in less than 24 hours. Italy had reported 13,882 cases with 803 deaths at that time. ICU resources in Lombardy were quickly overwhelmed. Before the outbreak, there were 720 ICU beds (5% of total beds). Within days, they increased to 130 COVID-19 ICU beds, and by March 7, there were 482. ICU admissions represented 12% of positive cases, much higher than China's 5%, likely due to different admission criteria. The death rate increased with age, ranging from under 1% for those under 59 to 16.6% for those aged 80–89. Model forecasts projected a potential dramatic increase in cases, with ICU capacity exceeding soon. At the time, Cecconi advised countries without major outbreaks to focus on training staff to handle highly contagious patients and to prioritize evidence-based treatment and supportive care. He also discouraged untested approaches that could harm patients, emphasizing the importance of evidence-based care.